Chapter 6: Problem 11
Explain the observations that led Zinder and Lederberg to conclude that the prototrophs recovered in their transduction experiments were not the result of \(\mathrm{F}^{+}\) mediated conjugation.
Chapter 6: Problem 11
Explain the observations that led Zinder and Lederberg to conclude that the prototrophs recovered in their transduction experiments were not the result of \(\mathrm{F}^{+}\) mediated conjugation.
All the tools & learning materials you need for study success - in one app.
Get started for freeInfluenza (the flu) is responsible for approximately 250,000 to 500,000 deaths annually, but periodically its toll has been much higher. For example, the 1918 flu pandemic killed approximately 30 million people worldwide and is considered the worst spread of a deadly illness in recorded history. With highly virulent flu strains emerging periodically, it is little wonder that the scientific community is actively studying influenza biology. In \(2007,\) the National Institute of Allergy and Infectious Diseases completed sequencing of 2035 human and avian influenza virus strains. Influenza strains undergo recombination as described in this chapter, and they have a high mutation rate owing to the error-prone replication of their genome (which consists of RNA rather than DNA). In addition, they are capable of chromosome reassortment in which various combinations of their eight chromosomes (or portions thereof) can be packaged into progeny viruses when two or more strains infect the same cell. The end result is that we can make vaccines, but they must change annually, and even then, we can only guess at what specific viral strains will be prevalent in any given year. Based on the above information, consider the following questions: (a) Of what evolutionary value to influenza viruses are high mutation and recombination rates coupled with chromosome reassortment? (b) Why can't humans combat influenza just as they do mumps, measles, or chicken pox? (c) Why are vaccines available for many viral diseases but not influenza?
A plaque assay is performed beginning with \(1 \mathrm{mL}\) of a solution containing bacteriophages. This solution is serially diluted three times by combining \(0.1 \mathrm{mL}\) of each sequential dilution with \(9.9 \mathrm{mL}\) of liquid medium. Then \(0.1 \mathrm{mL}\) of the final dilution is plated in the plaque assay and yields 17 plaques.What is the initial density of bacteriophages in the original \(1 \mathrm{mL} ?\)
Describe the role of heteroduplex formation during transformation.
Differentiate between generalized and specialized transduction.
Describe the origin of \(\mathrm{F}^{\prime}\) bacteria and merozygotes.
What do you think about this solution?
We value your feedback to improve our textbook solutions.